Xin Hu

6.0k citations
78 papers · 3.9k indexed · 3 hit papers · h-index 34
Topics
Cancer-related molecular mechanisms research (15 papers)RNA modifications and cancer (11 papers)Cancer Genomics and Diagnostics (9 papers)

In The Last Decade

Xin Hu

74 papers receiving 3.8k citations

Hit Papers

Metabolic-Pathway-Based Subtyping of Triple-Negative Brea...202020262022202420202022202250100150200250

Peers

Xin Hu
Comparison fields: 5 of 119
  • Molecular Biology 2.5k
  • Cancer Research 1.5k
  • Oncology 1.1k
  • Pulmonary and Respiratory Medicine 624
  • Immunology 428
Replace Naoya Sakamoto with:
Naoya Sakamoto Japan
Chih‐Yang Wang Taiwan
Gennadi V. Glinsky United States
Qinglei Gao China
Zhi Dai China
Yujuan Zhou China
Ping Wei China
Jing‐Ping Yun China
Zhuchu Chen China
Hsiang‐Fu Kung Hong Kong
Xin Hu relative to Naoya Sakamoto Japan Naoya Sakamoto's profile →
Citations per field
00.5×
Naoya Sakamoto · 1×
Citations per year

Countries citing papers authored by Xin Hu

Since Specialization
Citations

This map shows the geographic impact of Xin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Hu more than expected).

Fields of papers citing papers by Xin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Hu. The network helps show where Xin Hu may publish in the future.

Co-authorship network of co-authors of Xin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Hu. A scholar is included among the top collaborators of Xin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Hu. Xin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 0
5 52
6 28
7 194
8 102
9 265
10 15
11 96
12 25
13 65
14 7
15 71
16 55
17
Berberine interfered with breast cancer cells metabolism, balancing energy homeostasis
1
18 20
19 5
20 62

About Xin Hu

Xin Hu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 78 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (11 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.1k citations) and Molecular Biology (2.5k citations). Xin Hu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Da‐Qiang Li, T Maciag, Robert Friesel, Yi‐Rong Liu, Ding Ma, Yi Xiao, Yi‐Zhou Jiang, William H. Shelver, Zhi-Ming Shao and Ke‐Da Yu. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026